Literature DB >> 20153470

Surrogate end points in women's health research: science, protoscience, and pseudoscience.

David A Grimes, Kenneth F Schulz, Elizabeth G Raymond.   

Abstract

A surrogate end point (e.g., a laboratory test or image) serves as a proxy for a clinical end point of importance (e.g., fracture, thrombosis, or death). Adoption and use of surrogate end points lacking validation, especially in cardiovascular medicine, have caused thousands of patients' deaths, a serious violation of the ethical principle of beneficence. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153470     DOI: 10.1016/j.fertnstert.2009.12.054

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.

Authors:  Wolfgang Junge; Uwe Mellinger; Susanne Parke; Marco Serrani
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 2.  Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple.

Authors:  Kurt T Barnhart
Journal:  Fertil Steril       Date:  2014-05       Impact factor: 7.329

Review 3.  Estrogen and thrombosis: controversies and common sense.

Authors:  Thomas G DeLoughery
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

4.  Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.

Authors:  Christine Klipping; Ingrid Duijkers; Susanne Parke; Uwe Mellinger; Marco Serrani; Wolfgang Junge
Journal:  Drugs R D       Date:  2011

Review 5.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; Alissa Bernholc; Mario Chen; Thomas W Grey; Conrad Otterness; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18

6.  Nomegestrol acetate-17b-estradiol for oral contraception.

Authors:  Anne Burke
Journal:  Patient Prefer Adherence       Date:  2013-06-27       Impact factor: 2.711

7.  Translational toxicology: a developmental focus for integrated research strategies.

Authors:  Claude Hughes; Michael Waters; David Allen; Iyabo Obasanjo
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-30       Impact factor: 2.483

Review 8.  New and emerging contraceptives: a state-of-the-art review.

Authors:  Luis Bahamondes; M Valeria Bahamondes
Journal:  Int J Womens Health       Date:  2014-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.